Schick reports 1998 financial results

Article

Digital imaging firm Schick Technologies this month reported a big jump in revenues as the firm's products begin to hit the market. For the year (end-March), Schick posted revenues of $38.5 million, up 139% compared with $16.1 million the year before.

Digital imaging firm Schick Technologies this month reported a big jump in revenues as the firm's products begin to hit the market. For the year (end-March), Schick posted revenues of $38.5 million, up 139% compared with $16.1 million the year before. The company had net income for the year of $2.4 million, compared with a net loss of $352,000 in 1997. The 1998 figures include a one-time patent litigation settlement of $600,000.

Schick reported that sales of its accuDEXA bone densitometer are going well. In addition, the Long Island City, NY, company reported that it received 510(k) clearance from the Food and Drug Administration for an additional application for accuDEXA: use of the system to help physicians determine the risk of fracture. AccuDEXA received its initial 510(k) market clearance in December for assessing bone mineral density (SCAN 4/15/98).

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.